Synthetic genomics turning living cells into biofactories.
| Date | Round | Amount |
|---|---|---|
| Sep 2024 | Series A UK synthetic-genomics startup Constructive Bio raised $58M in the first close of its Series A led by Ahren, OMX Ventures and Paladin Capital. | $58M |
| Aug 2022 | Seed Constructive Bio, a Cambridge synthetic-biology MRC spin-out, raised $15M seed led by Ahren with Amadeus Capital Partners. | $15M |